FDA officers are off on a three-week dash to overview J&J COVID-19 vaccine knowledge


Clinical Trial of Johnson & Johnson Covid-19 Vaccine
Johnson & Johnson launched knowledge from its vaccine scientific trial final week.

Johnson & Johnson introduced yesterday that it had formally requested the Meals and Drug Administration to authorize its COVID-19 vaccine, kicking off a course of that may ship its one-shot immunization by a gauntlet of analysts and specialists.

If all goes as anticipated and the company agrees that the advantages of the vaccine outweigh the dangers, the US may have a 3rd shot out there by the top of February. Specialists hope that this vaccine — which solely takes one dose and may be saved within the fridge — may speed up the US’ vaccination marketing campaign.

Over the following few weeks, FDA officers will work at breakneck speeds to overview the info submitted by Johnson & Johnson. Then, they’ll write up a report and submit it to…

Proceed studying…

Related Posts

Leave a Reply

Your email address will not be published.